PANDEMIC REPORT: Drug trial at Airway Therapeutics; pollution and severe COVID

Airway Therapeutics to begin clinical trial

The FDA has accepted Airway Therapeutics’ application for an investigational drug treatment for COVID-19. Airway is now initiating a Phase 1b clinical trial for the protein replacement therapy, known as AT-100AT-100, for use in COVID-19 patients to confirm its feasibility, safety and tolerability..

Baptist Health; Zero readmissions with monitoring platform

When the pandemic hit last year, Baptist Health in Louisville was in the middle of piloting an AI-powered remote monitoring platform for CHF and COPD patients. They pivoted to use it for COVID-19 patients and the result was that they achieved zero readmissions with those patients.

Special mask destroys virus’ ability to infect

A researcher from the University of Dayton Research Institute designed a mask that is coated with silver nanoparticles that destroy the COViD-19 virus’s ability to infect.

Tech key to survival of restaurants during COVID-19

Kansas city-based Menufy develops e-commerce software and custom websites for restaurants to enable online ordering. The tech was key to the survival of many restaurants during the pandemic.

Pollution and severe COVID-19

Researchers at the University of Cincinnati have found that long-term exposure to polluted air could increase the risk of severe COVID-19 in people with respiratory diseases like asthma and COPD.